Drug Shows Early Promise for Advanced Lung Cancer

April 19, 2015 1:00 PM

3 0

SUNDAY, April 19, 2015 (HealthDay News) -- A new drug that boosts the immune system's cancer-fighting potential is showing early promise for some patients with advanced lung cancer.

The drug, marketed as Keytruda, was recently approved in the United States for treating advanced melanoma, but is not yet approved for lung cancer.

Also read: GE in talks to buy oilfield services provider Baker Hughes: WSJ

Read more

To category page